The Diagnosis Looks Favorable for Quest Diagnostics (DGX)

Shares of Quest Diagnostics Incorporated DGX are higher on the session by 0.02%, currently trading at $49.07. The stock has been moving largely lower over the past six months, but has managed to regain the 50-day moving average as of late, bouncing off of historical support at $45.00. Options traders think there is more gas in the tank and are buying calls. A short while ago the November $55.00 call was purchased 1,225 times, on the offer, on open interest of 1,558 contracts. Call volume is now running at 6.66x the daily average with 98% of all calls traded being purchases on the offer. Quest Diagnostics Incorporated is a provider of diagnostic testing, information and services. The company offers United States patients and physicians access to diagnostic testing services through its nationwide network of laboratories and company-owned patient service centers. For more great research like this, as well as how to play it through options…please visit Benzinga's Options & Volatility Edge and Benzinga's Cash Generator.